Concepedia

Clinical predictive factors of pathologic complete response in locally advanced rectal cancer

Francesca De Felice, Luciano Izzo, Daniela Musio, Anna Lisa Magnante, Nadia Bulzonetti, Federico Pugliese, Paolo Izzo, Pierfrancesco Di Cello, Pietro Lucchetti, Sara Izzo,

Oncotarget · 2016 · 49 citations · 18 references

DOIFull text

Open access

Abstract

Tumor size at diagnosis could be used to predict pCR, and thus to individualize therapy in LARC patients management. Validation in other studies is needed.

References

18

Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years

Rolf Sauer, Torsten Liersch, Susanne Merkel et al. · Journal of Clinical Oncology · 2012 · 2.1K citations · Full text

Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data

Monique Maas, Patty J. Nelemans, Vincenzo Valentini et al. · The Lancet Oncology · 2010 · 1.9K citations

, , +11

Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial

C. Aschele, L. Cionini, Sara Lonardi et al. · Journal of Clinical Oncology · 2011 · 762 citations · Full text

Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2

Jean‐Pierre Gérard, D. Azria, S. Gourgou-Bourgade et al. · Journal of Clinical Oncology · 2010 · 747 citations

Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial

Claus Rödel, Torsten Liersch, Heinz Becker et al. · The Lancet Oncology · 2012 · 694 citations

, , +8